Assertion: antibody | /r/HasProperty | effective
Facets:
value: against sars-cov-2
type: TRANSITIVE-OBJECT
value: potentially
type: DEGREE
Source sentences:
text: The Court found that there are at least two ways to identify new antibodies potentially covered by a patent claim: either from scratch, with techniques such as phage display or transgenic mice, or through variants of antibodies known to be effective.
text: In addition to revealing the surprisingly long-lasting immunity to such viruses, these antibodies could be effective treatments to have on hand if another virus similar to the 1918 flu breaks out in the future.
text: Twist Biopharma is currently building a proprietary synthetic antibody discovery library based on these sequences to identify the antibodies that may potentially be effective against SARS-CoV-2, and will work together with VUMC on these efforts.
text: All statements other than statements of historical facts contained herein, including without limitation Twist’s ability to supply synthetic genes and antibodies to VUMC in the quantity and quality required by VUMC, the success of the P3 program in achieving its objective, the ability to successfully select antibody sequences that have the potential to effectively treat COVID-19, the ability to successfully identify lead antibody candidates for further development and the ability of Twist’s proprietary synthetic antibody discovery library to help identify antibodies that are effective against SARS-CoV-2, are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.